Greggs PLC
09 June 2005
On 9 June 2005 Greggs plc ("the Company") was notified that on 9 June 2005, the
trustees of the Greggs Employee Benefit Trust, including Ian Gregg, Sir Michael
Darrington and Malcolm Simpson (directors of the Company) sold 9,812 ordinary
shares of 20p each in the Company (0.0807% of the issued shares) at £28.21 per
share to employees on the exercise of options granted pursuant to the Company's
Savings Related Share Option Scheme.
After the disposal, the trustees of the Employment Benefit Trust hold 60,072
shares (0.49% of the issued shares).
The total beneficial and non-beneficial holdings of each relevant director
(excluding interests in share options) following this notification are as
follows:
Beneficial Non-beneficial
Ian Gregg 144,835 (1.19%) 60,072 (0.49%)
Malcolm Simpson 87,986 (0.72%) 88,673 (0.73%)
Sir Michael Darrington 78,802 (0.65%) 60,072 (0.49%)
(Both of the Executive Directors, Sir Michael Darrington and Malcolm Simpson,
have a potential beneficial interest in the 60,072 shares held by the Employee
Benefit Trust shown above as part of their respective non-beneficial interests)
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.